News About: Pharm. Industry
Boryung to foster Astrix for a public healthcare drugBoryung has adopted a marketing strategy for "Astrix" (a drug for thrombosis) to be fostered as a public healthcare remedy. Astrix is a 100mg low dosed aspirin preparation for t...
|
KFDA approved additional indication for Wyeth Enbrel.
The KFDA approved Enbrel for the indication of ringworm in addition to its rheumatoid arthritis, especially for the patients who are moderate to severe ringwom diseases and resistant to other treatments as available. ...
Industry alerts on the influx of Swiss drugs into Korea
Korea and Switzerland have made a free trade agreement (FTA), which may trigger the drug industry to worry about possible influx of many Swiss pharmaceutical products into Korea.
Following the FTA settlement with C...
Production of foreign multinational corporations plummeted
While the foreign multinational drug corporations imported drugs on an increasing tendency, the production showed ever declining pace according to the 2004 pharmaceutical production statistics compiled by the KPMA.
...
Labfrontier to serve for comparative dissolution tests.
Labfrontier company (representative: Park Jong-sae) announced to start a commercial service business for the comparative drug dissolution test after completing installation of all required facilities including an auto...
Quintiles to provide HR services for drug industries.
It is very interested to note that a company named Quintiles announced to provide a human resource management service, especially for the retired pharmaceutical salesmen and medical representatives so that a drug comp...
Daewoong wholesale policy on controversy.
It is very likely for the wholesale policy recently announced by Daewoong partly to modify, which has been in controversy among the related drug wholesalers for its acceptance and the national pharmacist credit union ...
Janssen Korea significantly to invest for clinical studies in Korea.
Starting from this year to 2007 Janssen Korea plans to put over U$200 million investment for the clinical studies in Korea, which is about 40 folds higher than U$500,000 in 2004.
The investment schedule shows $4,10...
Cheil to reset up 257 BW of sales forecast this year.
During the business trip to the regional branches from July 5 to 8, President Seong Seok-jae of Cheil Pharm. Co. reset this year sales forecast from 247 BW to 257 BW, urging all sales staffs to put whole efforts for t...
KPTA to cooperate with health authority of Vietnam.
The Korea Pharmaceutical Traders Association (KPTA) visited to the Vietnamese health authority and the drug traders association for one week from June 27, and discussed drug export business and other cooperative subje...
